SpeeDx
Sydney, AU · 2 known investors
Find your way into SpeeDx
311 people in our graph share verified history with the SpeeDx team — schools, employers, funds. One of them is your warm intro.
Teresa Chanunlockedknows Elisa Mokany · together at Johnson & Johnson (overlapped)
×3knows the team · via UNSW
×8knows the team · via Johnson & Johnson
SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions. The tests are designed for use with standard laboratory equipment in clinical settings.
Founders & leadership
AT
Alison ToddCo-founder
EM
Elisa MokanyinCo-founderCo-founder of SpeeDx, Elisa Mokany has spent 17 years building the company, which operates offices in Sydney, London, and the United States. She brings expertise in molecular diagnostics, pre-clinical and clinical regulatory processes, and diagnostic technology development including nucleic acid amplification and sample handling systems.
Investors · 2
Funding
SEC filings, press & company announcements$26M disclosed across 1 round · 2023
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does SpeeDx do?
- SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions. The tests are designed for use with standard laboratory equipment in clinical settings.
- Who founded SpeeDx?
- SpeeDx was founded by Alison Todd, Elisa Mokany.
- Who are SpeeDx's investors?
- SpeeDx's investors include Tenmile, Northpond Ventures.
- How much funding has SpeeDx raised?
- SpeeDx has disclosed $26M raised across 1 round.
- Where is SpeeDx headquartered?
- SpeeDx is headquartered in Sydney, AU.